(Society of Nuclear Medicine and Molecular Imaging) Researchers have developed a new PET imaging agent that could help guide and assess treatments for people with various neurological diseases, including Alzheimer's, Parkinson's, and multiple sclerosis. The agent targets receptors in nerve cells in the brain that are involved in learning and memory. The study is featured in the April issue of the Journal of Nuclear Medicine.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2pYns4w
No comments:
Post a Comment